From Medscape Nephrology

Medscape Medical News from the:

XLIX European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) Congress

May 24 - 27, 2012; Paris, France

This coverage is not sanctioned by, nor a part of, the European Renal Association–European Dialysis and Transplant Association.

Conference News

ERA-EDTA Sevelamer Linked to Lower CV Risk With Hemodialysis
Medscape Medical News, June 27, 2012
ERA-EDTA Patients on Peritoneal Dialysis May Benefit From Vitamin D
Medscape Medical News, June 22, 2012
ERA-EDTA Olmesartan No Better Than Standard Therapy in HD Patients
Medscape Medical News, June 15, 2012
ERA-EDTA Phosphate-Binding Agents Lower Mortality
Medscape Medical News, June 14, 2012
ERA-EDTA No Benefit of Eculizumab in Shiga-Toxigenic E coli Outbreak
Medscape Medical News, June 9, 2012
ERA-EDTA Eculizumab Restores Renal Function in Atypical HUS Patients
Medscape Medical News, June 7, 2012
ERA-EDTA Vitamin D Lowers Hepcidin Levels in CKD Patients
Medscape Medical News, June 1, 2012
ERA-EDTA Weight Loss With Bardoxolone Methyl Treatment of CKD
Medscape Medical News, May 29, 2012
ERA-EDTA ACE Inhibitor Plus ARB Does Not Prevent Diabetic Nephropathy
Medscape Medical News, May 28, 2012
ERA-EDTA Low Glucose With Peritoneal Dialysis Better for Diabetics
Medscape Medical News, May 27, 2012

Medscape Nephrology© WebMD, LLC

Previous ERA-EDTA Coverage

XLVIII ERA-EDTA Congress

XLVII ERA-EDTA Congress

All material on this website is protected by copyright, Copyright © 1994-2020 by WebMD LLC. This website also contains material copyrighted by 3rd parties.